Patents by Inventor Ericka Simpson

Ericka Simpson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070017809
    Abstract: The invention relates to an assay for discriminating between amyotrophic lateral sclerosis (ALS) patients and patients with ALS-like disorders that express symptoms like ALS. The method is based on the use of 2-dimensional (2D) gel electrophoresis to separate the complex mixture of proteins found in blood serum, the quantitation of a group of identified biomarkers, and the biostatistical analysis of the concentration of the identified biomarkers to differentiate patients having ALS from patients having other ALS-like disorders.
    Type: Application
    Filed: July 17, 2006
    Publication date: January 25, 2007
    Applicant: Power3 Medical Products, Inc.
    Inventors: Ira Goldknopf, Essam Sheta, Brian Folsom, Stanley Appel, Albert Yen, Ericka Simpson
  • Publication number: 20060115855
    Abstract: The present invention relates to a biomarker for neurodegenerative disease, including amyotrophic lateral sclerosis (ALS), Alzheimer's (AD), and Parkinson's (PD) disease. More particularly, the present invention relates to the identification of the FK 506-binding protein 7, or prolylisomerase, as a biomarker useful for the detection, diagnosis, and differentiation of neurodegenerative disease, including but not limited to ALS, AD, and PD.
    Type: Application
    Filed: January 19, 2005
    Publication date: June 1, 2006
    Applicant: Power3 Medical Products, Inc.
    Inventors: Ira Goldknopf, Essam Sheta, Stanley Appel, Ericka Simpson, Albert Yen
  • Publication number: 20060115867
    Abstract: The present invention relates to a biomarker for neurodegenerative disease, including amyotrophic lateral sclerosis (ALS), Alzheimer's (AD), and Parkinson's (PD) disease. More particularly, the present invention relates to the identification of a tripartite motif protein TRIM5 isoform gamma related protein as a biomarker useful for the detection, diagnosis, and differentiation of neurodegenerative disease, including but not limited to ALS, AD, and PD.
    Type: Application
    Filed: January 19, 2005
    Publication date: June 1, 2006
    Applicant: Power3 Medical Products, Inc.
    Inventors: Ira Goldknopf, Essam Sheta, Stanley Appel, Ericka Simpson, Albert Yen
  • Publication number: 20060115854
    Abstract: The present invention relates to a biomarker for neurodegenerative disease, including amyotrophic lateral sclerosis (ALS), Alzheimer's (AD), and Parkinson's (PD) disease. More particularly, the present invention relates to the identification of an acetyl-LDL receptor related protein as a biomarker useful for the detection, diagnosis, and differentiation of neurodegenerative disease, including but not limited to ALS, AD, and PD.
    Type: Application
    Filed: January 19, 2005
    Publication date: June 1, 2006
    Applicant: Power3 Medical Products, Inc.
    Inventors: Ira Goldknopf, Essam Sheta, Stanley Appel, Ericka Simpson, Albert Yen
  • Publication number: 20060115856
    Abstract: The present invention relates to a biomarker for neurodegenerative disease, including amyotrophic lateral sclerosis (ALS), Alzheimer's (AD), and Parkinson's (PD) disease. More particularly, the present invention relates to the identification of an 2?-5?-oligoadenylate synthetase like protein (p59 OASL) related protein as a biomarker useful for the detection, diagnosis, and differentiation of neurodegenerative disease, including but not limited to ALS, AD, and PD.
    Type: Application
    Filed: January 19, 2005
    Publication date: June 1, 2006
    Applicant: Power3 Medical Products, Inc.
    Inventors: Ira Goldknopf, Essam Sheta, Stanley Appel, Ericka Simpson, Albert Yen